EB06637 Goat Anti-AKR1C3 Antibody Price: $285.00 / €292,50 / £195.00 Size: 100µg specific antibody in 200µl EU Availability: In stock US Availability: In stock Click to add to EURO Shopping Cart (EU customers only) Click to add to US Dollar Shopping Cart (US customers only) Cart for UK (GBP) customers coming soon, meanwhile click for ordering info
Ordering Information As well as the shopping cart links above, you can order by email, phone, fax and mail. For country specific ordering information and shopping cart instructions please see Ordering Info. Please get in touch for world-beating prices on bulk orders and custom formulations. To order the immunizing peptide for blocking experiments please see Peptide Info.Target ProteinPrincipal Names: AKR1C3; DD3; HAKRB; HAKRe; HA1753; HSD17B5; hluPGFS; KIAA0119; aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II); prostaglandin F synthase; dihydrodiol dehydrogenase 3; chlordecone reductase homolog; hydroxysteroid (17-beta) dehydrogenase 5; type IIb 3-alpha hydroxysteroid dehydrogenase; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase Official Symbol: AKR1C3 Accession Number(s): NP_003730 Human GeneID(s): 8644 Immunogen Peptide with sequence CFASHPNYPYSDEY, from the C Terminus of the protein sequence according to NP_003730. Purification + Storage Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.Applications TestedPeptide ELISA: antibody detection limit dilution 1:32,000. Western Blot: Approx 35kDa band observed in human liver and human breast lysates (calculated MW of 36.9kDa according to NP_003730). Recommended concentration: 0.01-0.1µg/ml.
Species ReactivityTested: Human Expected from sequence similarity: Human Background ReferenceIczkowski KA, Qiu J, Qian J, Somerville MC, Rittmaster RS, Andriole GL, Bostwick DG. The dual 5-alpha-reductase inhibitor dutasteride induces atrophic changes and decreases relative cancer volume in human prostate. Urology. 2005 Jan;65(1):76-82. PMID: 15667867
Adobe PDF Version of Datasheet
For Research purposes only. Not for diagnostic or in vivo use. © Copyright Everest Biotech Ltd 2009 | Elite Grade Product 

EB06637 (0.03µg/ml) staining of human breast lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |